High-resolution computed tomography and health-related quality of life in Mycobacterium avium complex disease

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 6, 2013, Pages 829-835

  Maekawa, K ^a   Ito, Yutaka ^a   Oga, T ^a   Hirai, T ^a   Kubo, T ^a   Fujita, K ^a   Imai, S ^a   Niimi, A ^b   Chin, K ^a   Ichiyama, S ^a   Togashi, K ^a   Mishima, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

CT scores; High resolution computed tomography; Mycobacterium avium intracellulare complex; St George's respiratory questionnaire

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTERNAL CONSISTENCY; JAPAN; LEUKOCYTE COUNT; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SPUTUM CULTURE; TEST RETEST RELIABILITY;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; JAPAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878286146     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0672     Document Type: Article

References (31)

1. Griffith D E, Aksamit T, Brown-Elliott B A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
2. Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
3. Jones P W. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil sodium quality of life study group. Eur Respir J 1994; 7: 55-62. (Pubitemid 24075125)
4. Wilson C B, Jones P W, O'Leary C J, Cole P J, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997; 156: 536-541. (Pubitemid 27351991)
5. Chan S L, Chan-Yeung M M, Ooi G C, et al. Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest 2002; 122: 2030-2037. (Pubitemid 36051140)
6. Chang J A, Curtis J R, Patrick D L, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999; 116: 1175-1182. (Pubitemid 29535966)
7. Pasipanodya J G, Miller T L, Vecino M, et al. Using the St. George Respiratory Questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest 2007; 132: 1591-1598. (Pubitemid 350156017)
8. Mehta M, Marras T K. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med 2011; 105: 1718-1725.
9. Wallace R J Jr, Brown B A, Griffith D E, Girard W M, Murphy D T. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med 1996; 153: 1766-1772. (Pubitemid 26187897)
10. Tanaka E, Kimoto T, Tsuyuguchi K, et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1999; 160: 866-872. (Pubitemid 29442022)
11. Griffith D E, Brown B A, Girard W M, Griffith B E, Couch L A, Wallace R J Jr. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. Clin Infect Dis 2001; 32: 1547-1553. (Pubitemid 32458721)
12. Kobashi Y, Matsushima T, Oka M. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med 2007; 101: 130-138. (Pubitemid 44835234)
13. Lam P K, Griffith D E, Aksamit T R, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006; 173: 1283-1289. (Pubitemid 43848401)
14. Kuroishi S, Nakamura Y, Hayakawa H, et al. Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings. Eur Respir J 2008; 32: 147-152.
15. Ito Y, Hirai T, Maekawa K, et al. Predictors of five-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis 2012; 16: 408-414.
16. Song J W, Koh W J, Lee K S, et al. High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. Am J Roentgenol 2008; 191: W160-W166.
17. Charlson M E, Pompei P, Ales K L, MacKenzie C R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. (Pubitemid 17055592)
18. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 785-790.
19. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167: 544-549.
20. Fukuhara S, Ware J E Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 1998; 51: 1045-1053. (Pubitemid 28527160)
21. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. A comparison of the responsiveness of different generic health status measures in patients with asthma. Qual Life Res 2003; 12: 555-563. (Pubitemid 37056047)
22. Brooks S M. Surveillance for respiratory hazards. ATS News 1982; 8: 12-16.
23. Zigmond A S, Snaith R P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370. (Pubitemid 13098606)
24. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
25. Andréjak C, Thomsen V Ø, Johansen I S, et al. Non-tuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010; 181: 514-521.
26. Prince D S, Peterson D D, Steiner R M, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863-868. (Pubitemid 19238618)
27. Kim R D, Greenberg D E, Ehrmantraut M E, et al. Pulmonary non-tuberculous mycobacterial disease. Prospective study of a distinct pre-existing syndrome. Am J Respir Crit Care Med 2008; 178: 1066-1074.
28. Wilson C B, Jones P W, O'Leary C J, et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J 1998; 12: 820-824. (Pubitemid 28491651)
29. Garrod R, Marshall J, Barley E, Fredericks S, Hagan G. The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). Prim Care Respir J 2007; 16: 236-240. (Pubitemid 47281449)
30. Wilson C B, Jones P W, O'Leary C J, Hansell D M, Cole P J, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J 1997; 10: 1754-1760. (Pubitemid 27368366)
31. Eshed I, Minski I, Katz R, Jones P W, Priel I E. Bronchiectasis: correlation of high-resolution CT findings with health-related quality of life. Clin Radiol 2007; 62: 152-159. (Pubitemid 46039403)